by Kevin Robb | May 22, 2025
For the first time, mesenchymal stromal cells (MSCs) can be used in routine clinical practice under the nod of regulatory approval in the United States. The MSC product known as Ryoncil was made available to patients in March 2025 following a historic decision from...
by Lyla El-Fayomi | Feb 24, 2025
I’m back with a post-holiday double edition of RMNU🔬! I cover stem cell patches for failing hearts, a novel skeletal tissue that’s been (re-)discovered, an update on BlueRock’s Parkinson’s therapy, and more. Bookmark, or dive right in! Pick of the Month(s) Stem cell...
by Laine Bodnar | Jun 12, 2024
Have you wondered how many cell and gene therapies (CGTs) have been approved in Canada? So did I. To track the number down, I first turned to my trusty internet search engine with hopes that a list of Health Canada-approved CGTs would already exist online. Notably, it...
by Tyler Wenzel | Nov 23, 2023
Cell therapies that replenish a healthy cell niche have long been an attractive approach to treat a variety of diseases, such as Parkinson’s disease, which are incurable and characterized by the loss of critical cell functions. The attractiveness of cell therapies is...
by Tara Fernandez | May 19, 2021
Scientists identify a drug combo that protects stem cells in culture, priming them for research and clinical applications. Picture this: The morning after working late on an important project, you reach for that hot cup of coffee—the caffeinated elixir that perks you...
Comments